Replies to post #142643 on Biotech Values

[DewDiligence]

Sounds like PFE spin, IMHO. Do you really think the drug has a chance to be approved on the current review cycle?

[acgood]

Interesting that both ALNY and ISIS act confidently that the TTR composite surrogate endpoint employed for tafamidis will be acceptable for their respective pivotal trials. Maybe not so definite?